Clinical Trials Browser

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05458284 2025-08-27

The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment

Phase 2 Active not recruiting

80 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT06135493 2025-04-24

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Phase 2 Completed

84 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

Phase 2 Withdrawn

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04675450 2023-06-08

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Phase 2 Withdrawn

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05351021 2023-03-09

Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

Phase 2 Completed

76 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04565600 2022-02-14

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Phase 2 Completed

144 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Somatoform Disorders

NCT02297412 2022-01-31

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Phase 2 Completed

47 enrolled 9 charts

Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Acute Pain

NCT02795572 2019-07-05

CIPN

Phase 2 Terminated

13 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT02230319 2015-10-01

Prevention of Paclitaxel Neuropathy With Cryotherapy

Phase 2 Unknown

39 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Clinical Trials

DETOXp

The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Evaluation of Hydroxychloroquine to Prevent CIPN

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

CIPN

Prevention of Paclitaxel Neuropathy With Cryotherapy